These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1402010)

  • 1. Epidermal interleukin 1 alpha functional activity and interleukin 8 immunoreactivity are increased in patients with cutaneous T-cell lymphoma.
    Lawlor F; Camp R; Greaves M
    J Invest Dermatol; 1992 Oct; 99(4):514-5. PubMed ID: 1402010
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidermal interleukin 1 alpha functional activity and interleukin 8 immunoreactivity are increased in patients with cutaneous T-cell lymphoma.
    Hansen ER; Vejlsgaard GL; Lisby S; Heidenheim M; Baadsgaard O
    J Invest Dermatol; 1991 Nov; 97(5):818-23. PubMed ID: 1919047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-8 immunoreactivity in epidermis of cutaneous T-cell lymphoma patients.
    Wismer JM; McKenzie RC; Sauder DN
    Lymphokine Cytokine Res; 1994 Feb; 13(1):21-7. PubMed ID: 8186321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TCRVb repertoire abnormalities in patients with cutaneous T-cell lymphoma.
    Papadavid E; Kapsimali V; Psarra A; Antoniou C; Papasteriadi C; Ekonomidou J; Anagnostou D; Nikolaou V; Kounaki D; Dalamaga M; Bamia C; Stratigos A; Stavrianeas N; Katsambas A
    Leuk Lymphoma; 2009 Jan; 50(1):130-2. PubMed ID: 19152167
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of interleukin-7 and interleukin-15 in cutaneous T-cell lymphoma.
    Zucker-Franklin D
    Blood; 2002 May; 99(9):3488; author reply 3488-9. PubMed ID: 12001911
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum levels of interleukin-18 are increased in patients with cutaneous T-cell lymphoma and cutaneous natural killer-cell lymphoma.
    Amo Y; Ohta Y; Hamada Y; Katsuoka K
    Br J Dermatol; 2001 Oct; 145(4):674-6. PubMed ID: 11703305
    [No Abstract]   [Full Text] [Related]  

  • 7. Cutaneous T-Cell Lymphoma. A hypothesis on disease pathophysiology involving deficiency in DNA repair.
    Thestrup-Pedersen K
    J Eur Acad Dermatol Venereol; 2016 Oct; 30(10):1682-1685. PubMed ID: 27501224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum interleukin-27 levels in patients with cutaneous T-cell lymphoma.
    Miyagaki T; Sugaya M; Shibata S; Ohmatsu H; Fujita H; Tamaki K
    Clin Exp Dermatol; 2010 Jun; 35(4):e143-4. PubMed ID: 19874357
    [No Abstract]   [Full Text] [Related]  

  • 9. Cutaneous T-cell lymphoma.
    Duvic M; Edelson R
    J Am Acad Dermatol; 2004 Jul; 51(1 Suppl):S43-5. PubMed ID: 15243507
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative study of cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma.
    Nagatani T; Miyazawa M; Matsuzaki T; Iemoto G; Kim ST; Baba N; Miyamoto H; Nakajima H
    Semin Dermatol; 1994 Sep; 13(3):216-22. PubMed ID: 7986691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-17 expression in neutrophils and Th17 cells in cutaneous T-cell lymphoma associated with neutrophilic infiltrate of the skin.
    Fontao L; Brembilla NC; Masouyé I; Kaya G; Prins C; Dupin N; Saurat JH; Chizzolini C; Piguet V
    Br J Dermatol; 2012 Mar; 166(3):687-9. PubMed ID: 21936854
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of cytotoxic skin-homing CD8+ lymphocytes in cutaneous cytotoxic T-cell lymphoma and pityriasis lichenoides.
    Wenzel J; Gütgemann I; Distelmaier M; Uerlich M; Mikus S; Bieber T; Tüting T
    J Am Acad Dermatol; 2005 Sep; 53(3):422-7. PubMed ID: 16112347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous T-cell lymphoma.
    Williams DS
    J Insur Med; 2006; 38(2):147-50. PubMed ID: 16845850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrodermic cutaneous T-cell lymphoma with disseminated pustulosis. Production of high levels of interleukin-8 by tumour cells.
    Poszepczynska E; Martinvalet D; Bouloc A; Echchakir H; Wechsler J; Bécherel PA; Boumsell L; Bensussan A; Bagot M
    Br J Dermatol; 2001 May; 144(5):1073-9. PubMed ID: 11359402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Jak3 signaling in IL-17 expression in malignant cutaneous T-cell lymphoma.
    Kwatra SG
    J Invest Dermatol; 2011 Sep; 131(9):1954-5; author reply 1955-6. PubMed ID: 21614012
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of cutaneous T cell lymphoma.
    Stadler R
    Skin Pharmacol Appl Skin Physiol; 2002; 15(3):139-46. PubMed ID: 12077466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous CD56+ large T-cell lymphoma associated with high serum concentration of IL-2.
    Wasik MA; Sackstein R; Novick D; Butmarc JR; Zhang Q; Vonderheid EC; Kadin ME
    Hum Pathol; 1996 Jul; 27(7):738-44. PubMed ID: 8698322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood flow cytometry based diagnosis in primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: implications for more extensive use.
    Benetatos L; Dova L; Baxevanos G; Kolaitis NI; Bourantas KL; Vartholomatos G
    Cytometry B Clin Cytom; 2009 Mar; 76(2):102-6. PubMed ID: 18956469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous lymphoma. Foreword.
    Johnstone PA
    Curr Probl Cancer; 2008; 32(2):42. PubMed ID: 18325432
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased CCR4 expression in cutaneous T cell lymphoma.
    Ferenczi K; Fuhlbrigge RC; Pinkus J; Pinkus GS; Kupper TS
    J Invest Dermatol; 2002 Dec; 119(6):1405-10. PubMed ID: 12485447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.